or Try an Advanced Search...

    Technical Analysis for TNFA - TNF Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.60 6.96% 0.04
    TNFA closed up 6.96 percent on Thursday, February 6, 2025, on 4.14 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical TNFA trend table...
    Date Alert Name Type % Chg
    Volume Surge Other 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 6.96%
    Lower Bollinger Band Walk Weakness 6.96%
    Older End-of-Day Signals for TNFA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 9 hours ago
    Possible Inside Day about 9 hours ago
    Rose Above Lower Bollinger Band about 11 hours ago
    2x Volume Pace about 11 hours ago
    1.5x Volume Pace about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    TNFA Chart by TradingView

    Profile

    • Earnings date: Unknown
    TNF Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Pain Autoimmune Disease Disorders Chronic Pain Depression Epilepsy Analgesics Drug Products Cannabidiol Neurodegenerative Disease Sjögren Syndrome Anticonvulsants

    Is TNFA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 29 TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment
    Dec 19 TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs
    Dec 9 TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference
    Oct 2 TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market
    Aug 21 TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline
    See more TNFA news...

    Comments

    Indicators

    Indicator Value
    52 Week High 2.16
    52 Week Low 0.558
    Average Volume 307,948
    200-Day Moving Average 0.00
    50-Day Moving Average 1.18
    20-Day Moving Average 1.07
    10-Day Moving Average 0.89
    Average True Range 0.14
    RSI (14) 26.47
    ADX 12.83
    +DI 16.52
    -DI 30.15
    Chandelier Exit (Long, 3 ATRs) 1.10
    Chandelier Exit (Short, 3 ATRs) 0.98
    Upper Bollinger Bands 1.58
    Lower Bollinger Band 0.56
    Percent B (%b) 0.04
    BandWidth 94.89
    MACD Line -0.16
    MACD Signal Line -0.10
    MACD Histogram -0.0613
    Fundamentals Value
    Market Cap 1.42 Million
    Num Shares 2.37 Million
    EPS -10.48
    Price-to-Earnings (P/E) Ratio -0.06
    Price-to-Sales 0.00
    Price-to-Book 0.44
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.72
    Resistance 3 (R3) 0.72 0.69 0.70
    Resistance 2 (R2) 0.69 0.66 0.69 0.69
    Resistance 1 (R1) 0.64 0.64 0.62 0.64 0.69
    Pivot Point 0.61 0.61 0.60 0.60 0.61
    Support 1 (S1) 0.56 0.58 0.54 0.56 0.51
    Support 2 (S2) 0.53 0.56 0.52 0.50
    Support 3 (S3) 0.48 0.53 0.50
    Support 4 (S4) 0.48